Abstract

Author(s)

Smonda Kok

Affiliations

Eastern Health

Introduction

Individuals living with Schizophrenia or Schizoaffective Disorder prescribed on Clozapine are at increased risk of cardiometabolic complications, including weight gain, dyslipidemia, and type 2 diabetes. Despite this, access to tailored nutrition support in community mental health settings remains limited. The Central East Clozapine Clinic was established in April 2024 to support consumers with ongoing Clozapine treatment who no longer require community mental health case management. This created an opportunity to embed a dietitian into the service to address Clozapine-associated metabolic risks.

Method

A dietitian was integrated into the Central East Clozapine Clinic, providing weekly on-site dietetic service. Consumers managed under the clinic were offered monthly 1:1 consultations to address metabolic health concerns including weight gain, bowel health, and food insecurity. Referral pathways were established with clinic psychiatrists and nurses. Data collected included anthropometry, biochemical markers, bowel function, and consumer feedback. Staff reflections were also gathered to evaluate the integrated model.

Results & findings

Consumers (n=6) described feeling “supported and listened to” and valued that the service was free, local, and flexible, with phone consultations available to reduce anxiety. One consumer reported feeling more “in control” of their health after learning.